Overview

Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $4.64 + 0.20 (4.50%)
ExchangeNASDAQ GS
Volume280,687
Today's Open$4.48
Previous Close$4.44
Data as of 06/22/17 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $4.64 with a 52 week high of $15.80 and a 52 week low of $2.94.
Recent News

June 02, 2017

NantHealth to Present at the Jefferies Healthcare Conference on June 7, 2017

CULVER CITY, Calif.--(BUSINESS WIRE)--Jun. 2, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that the company will present at the Jefferies Healthcare Conference at 4 p.m. ET, on Wednesday, June 7, 2017 at the Grand Hyatt hotel, New York City. The company also said that Patrick Soon-Shiong, M.D., chief executive officer and chairman of NantHealth, has been invited to pa...

Read More >

May 23, 2017

NantHealth Names Ronald A. Louks as Chief Operating Officer

CULVER CITY, Calif.--(BUSINESS WIRE)--May 23, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced the appointment of Ronald A. Louks as its Chief Operating Officer. “Ron brings senior level leadership and excellent experience, gained at some of the most highly regarded and well recognized companies in the world, including Blackberry, HTC and Sony Ericsson,” said Patrick ...

Read More >

May 10, 2017

NantHealth Appoints Dr. Sandeep Reddy as Chief Medical Officer

Company adds established oncology expert to leadership team CULVER CITY, Calif.--(BUSINESS WIRE)--May 10, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today the appointment of Sandeep (Bobby) Reddy, MD, as Chief Medical Officer. In his new position, Dr. Reddy will be responsible for overseeing education, outreach, clinical development programs, and clinical trials for GP...

Read More >

Upcoming Events
There are currently no events scheduled.